SciELO - Scientific Electronic Library Online

 
vol.3 número1Clinical and epidemiological characteristics of Polycystic Ovary Syndrome in a reference Hospital in ParaguayFrequency and clinical characteristics of pneumonia acquired in the community that require hospitalization índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista científica ciencias de la salud

versão On-line ISSN 2664-2891

Resumo

MONTIEL, Dora et al. Clinical and laboratory characteristics and mortality predictors of patients with COVID-19 admitted to the Hospital Nacional. Rev. cient. cienc. salud [online]. 2021, vol.3, n.1, pp.26-37. ISSN 2664-2891.  https://doi.org/10.53732/rccsalud/03.01.2021.26.

Introduction: the clinical forms of SARS CoV-2 range from asymptomatic, mild to severe symptoms with acute respiratory distress that can lead to death. Objective: to describe the clinical-epidemiological and laboratory characteristics and the predictors of mortality of adult patients with COVID-19 admitted to the National Hospital (Itauguá, Paraguay) between May and October 2020. Methodology: descriptive observational study of cross section of adult patients with COVID-19 admitted to the Hospital Nacional. The clinical and laboratory characteristics and the predictors of mortality were analyzed. Results: A total of 393 patients between 18 and 90 years of age (median: 56 years) were studied, the majority was male, from the Central Department. The main clinical manifestations were dyspnea, fever, and cough; 82.5% of the patients had some comorbidity, the most frequent was arterial hypertension (52.7%), followed by diabetes mellitus (30.8%) and obesity (24.4%). Among the laboratory findings, the most frequent were elevated levels of CRP (92.1%), ferritin (91%) and D-dimer (82%). 65.4% of the patients received heparin in an anticoagulant dose and 48.6% in a prophylactic dose. 93.4% received antibiotic coverage, 73.3% corticosteroids, 7.9% received convalescent plasma, and 3.8% remdesivir. Mortality was 30.3%, which was related (p≤ 0.05) with age ≥ 65 years, ICU admission, obesity, COPD, elevated values of D-dimer, LDH ferritin and procalcitonin. Conclusion: Mortality was high and was associated with prognostic factors reported previously.

Palavras-chave : COVID-19; comorbidity; mortality, Paraguay.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )